20250188433. Compositions (Regeneron Pharmaceuticals, .)
Appearance
COMPOSITIONS AND METHODS FOR INTERNALIZING ENZYMES
Abstract: compositions and methods for treating lysosomal storage diseases are disclosed. biotherapeutic complexes containing an internalization effector binding domain and a lysosomal replacement enzyme activity are disclosed. the biotherapeutic complexes are capable of entering cells, segregating to the lysosome, and delivering the replacement enzyme activity to the lysosome.
Inventor(s): Andrew Baik, Katherine Cygnar
CPC Classification: C12N9/2402 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media ))
Search for rejections for patent application number 20250188433